Fundraising FoxHeqet Therapeutics
1 known investors
Find your way into Heqet Therapeutics
Sign up to see every warm intro you have to Heqet Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Heqet Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Heqet Therapeutics is a pre-clinical stage biotech developing non-coding RNA-based therapies for cardiovascular diseases, with a focus on acute myocardial infarction. Its compounds target multiple pathways through the upregulation of certain non-coding RNAs to promote heart regeneration.
Founders & leadership
MG
Mauro GiaccaFounder (Professor of Cardiovascular Sciences)
Investors · 1
Claris Ventureslisted by Claris VenturesTorino
How we know: Claris Ventures's portfolio page · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Heqet Therapeutics do?
- Heqet Therapeutics is a pre-clinical stage biotech developing non-coding RNA-based therapies for cardiovascular diseases, with a focus on acute myocardial infarction. Its compounds target multiple pathways through the upregulation of certain non-coding RNAs to promote heart regeneration.
- Who founded Heqet Therapeutics?
- Heqet Therapeutics was founded by Mauro Giacca.
- Who are Heqet Therapeutics's investors?
- Heqet Therapeutics's investors include Claris Ventures.